Tg(SFTPC-EGFR*L858R)4-3Kkiu
Transgene Detail
|
Symbol: |
Tg(SFTPC-EGFR*L858R)4-3Kkiu |
Name: |
transgene insertion 4-3, Katsuyuki Kiura |
MGI ID: |
MGI:5789333 |
Transgene: |
Tg(SFTPC-EGFR*L858R)4-3Kkiu Location: unknown
|
Alliance: |
Tg(SFTPC-EGFR*L858R)4-3Kkiu page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(SFTPC-EGFR*L858R)4-3Kkiu expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
EGFR (1956) |
|
|
|
|
|
Mutation details: The full-length human cDNA with a T to G mutation at nucleotide 2573 resulting in the substitution of arginine for leucine at codon 858 and also tagged at the COOH-terminal end with FLAG is under the control of the human type II alveolar epithelial cell specific surfactant protein-C promoter. RT-PCR from hemizygous mice shows an approximate 1.5- to 3-fold greater expression of the transgene compared with endogenous Egfr. Western blot confirmed restricted expression to lung tissue.
(J:152157)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:152157 Ohashi K, et al., Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice. Cancer Res. 2009 Sep 1;69(17):7088-95 |
All: |
2 reference(s) |
|